The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDestiny Pharma. Share News (DEST)

Share Price Information for Destiny Pharma. (DEST)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 15.75
Bid: 15.50
Ask: 16.00
Change: -0.50 (-3.08%)
Spread: 0.50 (3.226%)
Open: 16.25
High: 16.25
Low: 15.70
Prev. Close: 16.25
DEST Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Appreciate gets court date; Corcel completes sale

Wed, 25th Jan 2023 20:03

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

----------

Appreciate Group PLC - Merseyside, England-based multi-retailer redemption product provider to corporate and consumer markets - Says that the court hearing to sanction the acquisition by PayPoint PLC will be held in the Royal Courts of Justice on February 23. In November, the Hertfordshire, England-based payment services provider PayPoint said it is buying Appreciate in a deal that values the company at around GBP83 million. PayPoint will pay 33 pence in cash and 0.019 of a new PayPoint share for each Appreciate share. PayPoint expects the takeover scheme to become effective in the first half of 2023.

----------

Corcel PLC - London-based mining and mineral resource development company - Completes the sale of a 100% stake in the Burwell Energy Storage project outside of Cambridge to Burwell AL Ltd for cash proceeds of GBP200,000, plus reimbursement of Corcel's grid deposit of GBP50,000. The outstanding balance of its corporate debt is GBP672,941, it says. "The sale of the Burwell energy storage project amidst ongoing timing uncertainties and potentially substantial additional upgrade costs at the local substation, completes the closure of the Flexible Grid Solutions business, which has been unwound at a small profit," CEO Scott Kaintz comments.

----------

Totally PLC - Derby, England-based provider of healthcare, corporate fitness and wellbeing services - Notes that its subsidiary Greenbrook Healthcare Ltd terminated its contracts for the provision of urgent treatment centres Central Middlesex Hospital, Ealing Hospital and Hillingdon Hospital. The contracts were due to expire on January 31, it adds. Says that Greenbrook will continue to provide services at the urgent treatment centres until there is an orderly handover to a temporary provider.

----------

Destiny Pharma PLC - Brighton-based clinical-stage biotechnology company - Picks up on an increased focus on the importance of infection prevention by the Center for Disease Control, Food & Drug Administration, and the medical community in general. Says that it is currently developing the XF-73 Nasal gel for the prevention of post-surgical infections. "The Centre for Disease Control's announcement clearly recognizes the need for new and effective decolonization agents and their importance for public health. They have made a clear call to simplify the pathway to regulatory approval and suggested the need for establishing new surrogate endpoints. Destiny Pharma views this as a very encouraging shift in the agency's thinking that could be very supportive to our clinical development of XF-73 Nasal," Chief Medical Officer Yuri Martina comments.

----------

AQRU PLC - London-based decentralised finance incubator - Notes that its subsidiary Accru Finance Ltd launched a liquidity pool to allow investors to generate yield from tax credit receivables originating from US Internal Revenue Service programmes. "We look forward to seeing retail and institutional investors worldwide take advantage of this opportunity to generate significant returns in the crypto and decentralised finance sectors," Chief Executive Philip Blows comments.

----------

East Star Resources PLC - gold and copper exploration company focused on Kazakhstan - Identifies a substantial copper-lead-zinc deposit at Rudny Altai VMS belt in Kazakhstan. Says that the deposit is within the greater Verkhuba Ore District. Reports historical flotation recovery rates of 94% to 96% copper and 60% to 90% zinc into concentrate. "Rudny Altai is a significant copper-producing region with excess processing capacity from both Glencore and KAZ Minerals. The identification of the Verkhuba Deposit is yet another validation our exploration thesis and we are excited to commence resource delineation drilling with additional updates to be delivered as digitisation of historic drilling continues and the 2023 exploration programme commences," CEO Alex Walker comments.

----------

Wentworth Resources PLC - Tanzania-focused natural gas production company - Notes that the operator of the Mnazi Bay asset got a notification from Tanzania Petroleum Development Corp in relation to the settlement of gas purchase invoices, which states that TPDC has requested that all future gas purchase invoices be settled in Tanzanian shillings by applying the exchange rate available on the date of payment. Expects this matter to be the subject of further discussion between the operator and TPDC.

----------

Gresham House Renewable Energy VCT 1 - investment firm - Cancels its interim dividend of 2 pence announced on December 21. Explains that a valuation adjustment which had previously been made to certain investments held by VCT 1 was reclassified as a realised loss. Believes that the distributable reserves of VCT 1 are reduced to a level at which the proposed interim dividend should not be paid.

----------

Landore Resources Ltd - Mining exploration and development company in Canada - Finds 822 parts per million nickel, 1087ppm copper, and 81 parts per billion platinum on the Felix-Lamaune prospects at its Junior Lake Property in Ontario, Canada. "The exploration campaign on the Felix-Lamaune area has clearly confirmed that, in addition to the advanced 1.5 million ounce BAM Gold deposit, the Junior Lake property hosts significant volumes of highly valuable battery metals, including palladium enriched sulphide Nickel with associated Cobalt and Copper, the presence of which has now been established through drilling for 11 kilometres from the Carrot Top Zone in the west to the B4-7, Alpha zone and VW Nickel-Copper-Cobalt-PGEs compliant deposits in the east, with the remaining 20 kilometres of the highly prospective greenstone-shear zone, transecting Landore's Junior Lake property, yet to be explored," CEO Bill Humphries says.

----------

Predator Oil & Gas Holdings PLC - operator of Guercif petroleum agreement onshore Morocco and developer of onshore fields in Trinidad - Suspends the MOU-2 well with an option to re-enter after reaching a depth of 1,260 metres measured depth. Says that the MOU-1 testing programme is being progressed and revised to gather as much information as possible on the connectivity of potential gas sands over a wide area. "MOU-2 has been an extremely challenging well to drill due to the presence of a particular geological formation not previously encountered. The prudent and safer option was to suspend the well and leave it in a state to re-enter once a better understanding of the mud programme required to drill this particularly complex interval efficiently and cost-effectively. Whilst this is not the result we wanted the pre-drill objectives and potential resources remain unchanged. The Star Valley rig will remain in place over the wellhead," Executive Chair Paul Griffiths comments.

----------

By Abby Amoakuh, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
29 Jun 2023 18:55

TRADING UPDATES: Ecofin US Renewables expects to pay reduced dividend

(Alliance News) - The following is a round-up of updates by London-listed companies, issued Thursday and not separately reported by Alliance News:

Read more
26 May 2023 10:51

Polarean shares down despite narrowed annual loss and optimism

(Alliance News) - Polarean Imaging PLC shares were down on Friday despite slimming its annual loss, as the company said it now will focus on gaining commercial traction and exploring further financing for its newly US Food & Drug Administration-approved Xenoview device.

Read more
25 May 2023 10:42

IN BRIEF: Destiny Pharma picks interim CEO as Clark makes quick exit

Destiny Pharma PLC - Brighton, England-based clinical-stage biotechnology company focused on preventing life-threatening infections - Chief Executive Officer Neil Clark steps down immediately "to pursue new challenges". Clark will "support [Destiny] for a limited period to ensure an orderly handover." Non-Executive Director Debra Barker will serve as interim CEO until Destiny appoints a permanent replacement. Barker has held "key roles" at Novartis AG and Polyphor AG, now named Spexis AG. She also has previously worked at Roche Holding AG, Polyneuron Pharmaceuticals AG and GSK PLC.

Read more
18 May 2023 15:03

UK shareholder meetings calendar - next 7 days

Friday 19 May 
Bank of Georgia Group PLCAGM
Permanent TSB Group Holdings PLCAGM
Sancus Lending Group LtdAGM
Monday 22 May 
Blackrock Latin American Investment Trust PLCAGM
Crossword Cybersecurity PLCAGM
Judges Scientific PLCAGM
Stelrad Group PLCAGM
Venture Life Group PLCAGM
Tuesday 23 May 
888 Holdings PLCAGM
Access Intelligence PLCAGM
Arix Bioscience PLCAGM
Bank of Ireland Group PLCAGM
Big Technologies PLCAGM
Bigblu Broadband PLCAGM
Centamin PLCAGM
CT Private Equity Trust PLCAGM
Empresaria Group PLCAGM
Epwin Group PLCAGM
Forterra PLCAGM
Fresnillo PLCAGM
Fulcrum Utility Services LtdGM re issue of conversion shares
Gresham Technologies PLCAGM
Harworth Group PLCAGM
Hilton Food Group PLCAGM
hVIVO PLCAGM
HydrogenOne Capital Growth PLCAGM
IQ-AI LtdAGM
JTC PLCAGM
K3 Business Technology Group PLCAGM
Pebble Group PLCAGM
Portmeirion Group PLCAGM
PPHE Hotel Group LtdAGM
Restaurant Group PLCAGM
Shell PLCAGM
Sherborne Investors (Guernsey) C LtdAGM
TMT Investments PLCAGM
Triple Point Income VCT PLCAGM
Triple Point Social Housing REIT PLCAGM
Trustpilot Group PLCAGM
Twentyfour Income Fund LtdAGM
Wickes Group PLCAGM
Xeros Technology Group PLCAGM
Wednesday 24 May 
4imprint Group PLCAGM
Adriatic Metals PLCAGM
Arbuthnot Banking Group PLCAGM
Artisanal Spirits Co PLCAGM
Bango PLCAGM
Coca-Cola Europacific Partners PLCAGM
Deliveroo PLCAGM
Deltic Energy PLCAGM
Distribution Finance Capital Holdings PLCAGM
Dunedin Enterprise Investment Trust PLCAGM
ECSC Group PLCCourt and General Meetings re Daisy Corporate Services Trading Ltd takeover
Empiric Student Property PLCAGM
Fidelity Japan Trust PLCAGM
HICL Infrastructure PLCAGM
Horizonte Minerals PLCAGM
Intertek Group PLCAGM
Ithaca Energy PLCAGM
Kelso Group Holdings PLCAGM
Lookers PLCAGM
M&G PLCAGM
Mercantile Investment Trust PLCAGM
Microlise Group PLCAGM
Mortgage Advice Bureau Holdings PLCAGM
National World PLCAGM
Ondine Biomedical IncAGM
Petershill Partners PLCAGM
Playtech PLCAGM
Quarto Group IncAGM
Real Estate Investors PLCAGM
Tullow Oil PLCAGM
US Solar Fund PLCAGM
Zotefoams PLCAGM
Thursday 25 May 
Alliance Pharma PLCAGM
Biome Technologies PLCAGM
Capital & Regional PLCAGM
Destiny Pharma PLCAGM
Ferrexpo PLCAGM
Fevertree Drinks PLCAGM
Headlam Group PLCAGM
Henry Boot PLCAGM
Hill & Smith PLCAGM
LBG Media PLCAGM
Life Science REIT PLCAGM
LSL Property Services PLCAGM
NAHL Group PLCAGM
Petrofac LtdAGM
Pharos Energy PLCAGM
Prudential PLCAGM
Regional REIT LtdAGM
Resolute Mining LtdAGM
RM PLCAGM
S&U PLCAGM
Sabre Insurance Group PLCAGM
Schroder Asian Total Return Investment Co PLCAGM
TBC Bank Group PLCAGM
Vanquis Banking Group PLCAGM
Zinc Media Group PLCAGM
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
2 May 2023 19:22

TRADING UPDATES: Macfarlane buys A&G Holdings for GBP3.6 million

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
13 Apr 2023 14:16

Destiny Pharma loss widens as it extends cash runway

(Sharecast News) - Biotechnology company Destiny Pharma reported a loss before tax of £7.7m in its 2022 results on Thursday, widening from £6.3m in the prior year.

Read more
13 Apr 2023 13:59

IN BRIEF: Destiny Pharma annual loss widens as expenses grow

Destiny Pharma PLC - Brighton, England-based clinical-stage biotechnology - Pretax loss widens to GBP7.7 million for 2022 from GBP6.3 million in 2021. Administrative expenses increase to GBP7.4 million from GBP6.0 million a year earlier. Research & development expenditure amounts to GBP4.9 million, up from GBP3.7 million in 2021. Looking ahead, Destiny Pharma says it will focus on completing the manufacturing scale-up to deliver clinical trial material for the NTCD-M3 clinical programme being run by our partner Sebela. Chief Executive Officer Neil Clark says: "Destiny Pharma has made good progress in 2022 and in the first quarter of 2023."

Read more
6 Apr 2023 15:42

UK earnings, trading statements calendar - next 7 days

Friday 7 April 
no events scheduled 
Monday 10 April 
no events scheduled 
Tuesday 11 April 
Devolver Digital IncFull Year Results
JTC PLCFull Year Results
Wednesday 12 April 
Argentex Group PLCQ3 Results
DP Eurasia NVFull Year Results
Everyman Media Group PLCFull Year Results
LBG Media PLCFull Year Results
Tharisa PLCTrading Statement
Thursday 13 April 
Brooks Macdonald Group PLCTrading Statement
Churchill China PLCFull Year Results
Destiny Pharma PLCFull Year Results
discoverIE Group PLCTrading Statement
Foresight Group Holdings LtdTrading Statement
Imperial Brands PLCTrading Statement
LSL Property Services PLCFull Year Results
Norcros PLCTrading Statement
PZ Cussons PLCTrading Statement
Tesco PLCFull Year Results
XP Power LtdTrading Statement
  
Copyright 2023 Alliance News Ltd. All Rights Reserved. 

Read more
4 Apr 2023 11:33

Destiny Pharma upbeat on infection prevention study

(Sharecast News) - Destiny Pharma said in an update on Tuesday that its novel medicine for preventing life-threatening infections, 'NTCD-M3', had been shown to colonise the gut successfully in a C difficile infection (CDI) model study after the administration of fidaxomicin.

Read more
24 Mar 2023 15:34

Destiny publishes 'important' research on its preoperative treatment candidate

(Sharecast News) - Clinical-stage biotechnology company Destiny Pharma announced the publication of landmark clinical data for 'XF-73' on Friday, in the US-based peer-reviewed journal Infection Control & Hospital Epidemiology.

Read more
16 Mar 2023 06:54

IN BRIEF: Destiny Pharma raises GBP7.3 million total in equity raise

Destiny Pharma PLC - Brighton, England-based clinical-stage biotechnology - Gets 33% take-up of open offer of shares, raising GBP340,000. Destiny raises GBP7.3 million gross in total from the open offer, plus a share placing and subscription, all at 35 pence per share. Net proceeds are GBP6.7 million, which will be used to support a collaboration agreement in the US with Sebela Pharmaceuticals for NTCD-M3, Destiny's lead asset for the prevention of clostridioides difficile infection recurrence.

Read more
24 Feb 2023 14:28

Destiny shares fall on fundraise discount despite USD570 million deal

(Alliance News) - Destiny Pharma PLC on Friday said that it has signed a collaboration agreement with Sebela Pharmaceuticals for NTCD-M3, its lead asset for the prevention of clostridioides difficile infection recurrence.

Read more
22 Dec 2022 14:06

Destiny Pharma jumps on 2022 progress

(Sharecast News) - Clinical-stage biotechnology company Destiny Pharma updated the market on its progress in 2022 on Thursday, including working to finalise a partnering agreement for 'NTCD-M3', which it described as its "most advanced" clinical programme, targeted at infection prevention.

Read more
22 Dec 2022 12:10

LONDON MARKET MIDDAY: UK stocks rise as Paris and Frankfurt head lower

(Alliance News) - Stock prices in London were higher at midday on Thursday, ahead of some key US economic data, while equities elsewhere were less buoyant.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.